The Scientific Discovery and Research Team at InSphero focuses on pioneering advancements in organotypic 3D microtissues for drug testing. Leveraging their expertise in liver and diabetes research, the team drives cutting-edge scientific discovery to enhance the predictability and safety of drug candidates.